Sustained expression of Fc-fusion cytokine following in vivo electroporation and mouse strain differences in expression levels

被引:12
作者
Jiang, JJ [1 ]
Yamato, E [1 ]
Miyazaki, J [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res G6, Suita, Osaka 5650871, Japan
基金
日本学术振兴会;
关键词
electroporation; gene delivery; IL10/Fc fusion cytokines; mouse strain differences; naked plasmid DNA;
D O I
10.1093/jb/mvg055
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously demonstrated that cytokine expression following intramuscular gene transfer of a naked plasmid is increased 2 logs by in vivo electroporation, but the relatively low expression levels of the encoded protein is still A limitation for successful gene therapy and gene function studies. We recently reported that the serum viral IL-10 levels achieved by electroporation-mediated intramuscular delivery of pCAGGS-vIL10, a viral IL-10-expressing plasmid, can be further enhanced by modifying the plasmid into an immunoglobulin fusion protein expression plasmid, pCAGGS-vlL10/Fc. Here we examined the applicability of this approach to the expression of an endogenous cytokine, IL-10, in two different inbred mouse strains. We obtained sustained high serum levels of IL-10 in C3H/HeJ mice (C3H), but the level and duration of the gene expression was mouse-strain dependent. Although the serum IL-10 level was also increased by using the IL-10/Fc gene plasmid in C57BL/6 mice (B6), IL-10/Fc and a luciferase reporter showed significantly lower levels in B6 than in C3H mice, and the persistence of pCAGGS-IL10/Fc expression ranged from several days in B6 mice to more than one month in C3H mice. These results suggest that the electroporation-mediated intramuscular delivery of the immunoglobulin fusion protein expression plasmid is simple and very efficient, but mouse strain differences in transgene expression should be taken into consideration in its use.
引用
收藏
页码:423 / 427
页数:5
相关论文
共 23 条
[1]   Gene transfer of Fc-fusion cytokine by in vivo electroporation: application to gene therapy for viral myocarditis [J].
Adachi, O ;
Nakano, A ;
Sato, O ;
Kawamoto, S ;
Tahara, H ;
Toyoda, N ;
Yamato, E ;
Matsumori, A ;
Tabayashi, K ;
Miyazaki, J .
GENE THERAPY, 2002, 9 (09) :577-583
[2]   Gene transfer into muscle by electroporation in vivo [J].
Aihara, H ;
Miyazaki, J .
NATURE BIOTECHNOLOGY, 1998, 16 (09) :867-870
[3]  
Bajetta E, 1998, CLIN CANCER RES, V4, P75
[4]  
CHERNOFF AE, 1995, J IMMUNOL, V154, P5492
[5]  
DANKO I, 1994, GENE THER, V1, P114
[6]   DIRECT GENE-TRANSFER INTO SKELETAL-MUSCLE INVIVO - FACTORS AFFECTING EFFICIENCY OF TRANSFER AND STABILITY OF EXPRESSION [J].
DAVIS, HL ;
WHALEN, RG ;
DEMENEIX, BA .
HUMAN GENE THERAPY, 1993, 4 (02) :151-159
[7]   NEW HOST-CELL SYSTEM FOR REGULATED SIMIAN VIRUS-40 DNA-REPLICATION [J].
GERARD, RD ;
GLUZMAN, Y .
MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (11) :3231-3240
[8]   Treatment of murine lupus with cDNA encoding IFN-γR/Fc [J].
Lawson, BR ;
Prud'homme, GJ ;
Chang, YG ;
Gardner, HA ;
Kuan, J ;
Kono, DH ;
Theofilopoulos, AN .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (02) :207-215
[9]  
LOTZE MT, 1985, J IMMUNOL, V135, P2865
[10]   High-efficiency gene transfer into skeletal muscle mediated by electric pulses [J].
Mir, LM ;
Bureau, MF ;
Gehl, J ;
Rangara, R ;
Rouy, D ;
Caillaud, JM ;
Delaere, P ;
Branellec, D ;
Schwartz, B ;
Scherman, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4262-4267